Posted inLondon Exchange
AstraZeneca agrees to acquire CinCor Pharma for upto $1.8 billion
LONDON, UK: AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma Inc., a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as…